These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7710969)

  • 21. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
    Licht RW; Qvitzau S
    Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study.
    Baca E; González de Chávez M; García-Toro M; Pérez-Arnau F; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):493-500. PubMed ID: 12691786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications for mianserin in relation to its absence of side-effects (author's transl)].
    Calanca MA
    Acta Psychiatr Belg; 1978; 78(5):781-6. PubMed ID: 375682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative clinical study of imipramine and mianserin in depressions].
    Chiriţă V; Cosmovici N; Boişteanu P; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(4):651-6. PubMed ID: 3915148
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mianserin and imipramin in depressive conditions (author's transl)].
    Zapletálek M; Hanus H; Kudrnová K
    Cesk Psychiatr; 1977 Aug; 73(4):234-8. PubMed ID: 336227
    [No Abstract]   [Full Text] [Related]  

  • 29. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W; Siwek M; Dudek D; Maczka G; Zieba A
    Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mianserin in acute cardiopathies. 27 cases recorded in a medical intensive care unit].
    Hourdebaigt-Larrusse P; Perchet H
    Ann Cardiol Angeiol (Paris); 1985 Nov; 34(9):637-41. PubMed ID: 4083774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
    Lopez-Ibor JJ; Conesa A;
    Curr Med Res Opin; 2004 Jun; 20(6):855-60. PubMed ID: 15200743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.
    Dimitriou EC; Logothetis JA; Paschalidou M
    Adv Biochem Psychopharmacol; 1982; 32():213-22. PubMed ID: 7046365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA; Wróbel A; Dudek D; Zieba A
    Pol J Pharmacol; 2004; 56(6):849-55. PubMed ID: 15662100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
    Besançon G; Cousin R; Guitton B; Lavergne F
    Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electroencephalogram study of mianserin in depressed patients.
    Irwin P; Fink M
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):43S-47S. PubMed ID: 341943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reboxetine addition in patients with mirtazapine-resistant depression: a case series.
    López-Muñoz F; Rubio G; Alamo C; García-García P; Pardo A
    Clin Neuropharmacol; 2006; 29(4):192-6. PubMed ID: 16855420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.